Natasha Kulviwat, a rising high school senior, discovered a protein that may serve as predictor for suicide and could potentially lead to new strategies for intervention and prevention.
"It's not a fact-finding mission, like we're kind of blindly throwing a spear," Dr. Randy Auerbach says. Instead, MAPS relies on established theories and data on suicidal behavior.
This study “adds to a growing literature of using electrophysiological outcomes, including mismatch negativity as predictive biomarkers,” commented Dr. Joshua Kantrowitz.
“This has been described in the literature going back to the Civil War,” Dr. Jeffrey Lieberman said. “It was called ‘Soldier's Heart’ because one of the features of PTSD was a rapid heartbeat.
A new study by Columbia University researchers found that infants at high risk for autism were less attuned to differences in speech patterns than low-risk infants.
Columbia Psychiatrists suggest that researchers, pharmaceutical companies, and the FDA reconsider placebo-controlled, relapse prevention studies in schizophrenia.
Dr. Jeffrey Lieberman and colleagues conclude that the time has come to cease the use of placebo in relapse prevention studies and encourage the use of active comparators.
A new study from Columbia University and New York State Psychiatric Institute offers insight into the development of delusions, which could lead to better treatments for people with psychosis.
"I expect that clinicians will change their practices by prescribing fewer benzodiazepines and more antidepressants for people with schizophrenia," Dr. T. Scott Stroup said.